MEMBER

Partner and Board Director

ATSUSHI USAMI

  • PROFILE
  • CAREER
  • MEDIA/PUBLICATION
Atsushi Usami focuses on seed/early-stage life science investments. He currently serves on the boards of Goryo Chemical Inc., EditForce Inc., Epigeneron Inc., Bugworks Research inc., bitBiome Inc., OriCiro Genomics, Inc., Celaid Therapeutics Inc., PURMX Therapeutics Co., Ltd., United Immunity, Co., Ltd., RegCell Co., Ltd. and others. He provides support for Life Science Innovation Network Japan (LINK-J).

Before joining UTEC, he worked as a strategy consultant at Mitsubishi Research Institute (MRI), serving pharmaceutical, medical device and other manufacturing companies across a range of areas including mid-to-long term management planning and new business development.
Atsushi Usami studied pharmacology and neuroscience.
He received a Ph.D. in pharmaceutical sciences from the University of Tokyo and is a pharmacist.
He worked as a consultant at MRI before joining UTEC in October 2013.

ATSUSHI USAMI’S
PORTFOLIO